Health Canada Grants Authorization for Leqembi® (lecanemab)
Go back to Health Canada Grants Authorization for Leqembi® (lecanemab)| BARNES GROUP, Inc. (NYSE: B) | Delayed: 47.00 -1.87 (3.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.87 | 52 Week High | $44.27 | |||
| Open | $48.18 | 52 Week Low | $30.07 | |||
| Day High | $48.55 | P/E | 35.88 | |||
| Day Low | $46.97 | EPS | $1.31 | |||
| Volume | 11,613,167 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 9.84 -0.27 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.11 | 52 Week High | $8.73 | |||
| Open | $10.03 | 52 Week Low | $2.86 | |||
| Day High | $10.03 | P/E | N/A | |||
| Day Low | $9.76 | EPS | $-3.82 | |||
| Volume | 504,283 | |||||
